Zumandimine

Active Ingredient(s): Drospirenone + Ethinyl Estradiol
FDA Approved: * March 26, 2018
Category: Birth Control / Contraceptive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zumandimine Overview

Drospirenone, sold under the brand names Yasmin and Angeliq among others, is a progestin medication which is used in birth control pills and in menopausal hormone therapy.[4][5][6] The medication is available only in combination with an estrogen.[4] It is taken by mouth.[6] Drospirenone is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like progesterone.[6] It has additional antimineralocorticoid and antiand...

Read more Zumandimine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Drospirenone

Recent Zumandimine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Drospirenone + Ethinyl Estradiol
  • Tablet: 0.25mg + 0.5mg, 0.5mg + 1mg, 3mg + 0.02mg, 3mg + 0.03mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (190 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 19 April 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.